Musk Says ‘Freedom Of Speech Is Worth Fighting For’ As Australia Drops Legal Fight Over Church Stabbing Videos On X
WNBA Sky-Fever Game With Controversial Foul On Caitlin Clark Drew 1.5 Million Viewers—Nearly 350% Above 2023 Regular Season ViewershipShares for companies focused on psychedelic medicines plummeted during premarket trading on Wednesday after independent experts advised the Food and Drug Administrationand stimulant drug MDMA, commonly known as ecstacy or molly, for post-traumatic stress disorder, a major setback for those hoping to open a new era of medicine for the often-outlawed substances.
Others hit include Relmada Therapeutics, which targets central nervous system conditions and was down around 5%, and Dublin drug developer GH Research, down around 3.5%.whether psychedelics can treat neurological diseases, appears to be a notable exception, with shares up nearly 2% during premarket trading.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: dcexaminer - 🏆 6. / 94 Read more »
Source: Forbes - 🏆 394. / 53 Read more »